Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

10.1016/j.annonc.2020.03.293

Saved in:

Bibliographic Details
Main Authors:	Schuler, M, Berardi, R, Lim, W-T, de Jonge, M, Bauer, TM, Azaro, A, Gottfried, M, Han, J-Y, Lee, DH, Wollner, M, Hong, DS, Vogel, A, Delmonte, A, Akimov, M, Ghebremariam, S, Cui, X, Nwana, N, Giovannini, M, Kim, TM
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Language:	English
Published:	ELSEVIER 2024
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology capmatinib MET amplification MET exon 14 MET mutation NSCLC GENE COPY NUMBER MET AMPLIFICATION ACQUIRED-RESISTANCE MUTATIONS EGFR ONARTUZUMAB COMBINATION ACTIVATION GEFITINIB ERLOTINIB
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/248920
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Be the first to leave a comment!